Cargando…
Exosomes in clinical trial and their production in compliance with good manufacturing practice
Exosomes, 60–200-nm extracellular vesicles secreted from cells, have been used as an active pharmaceutical ingredient or drug carrier in disease treatment. Human- and plant-derived exosomes are registered in clinical trials, but more complete reports are available for human-derived exosomes. Because...
Autores principales: | Chen, Yu-Shuan, Lin, En-Yi, Chiou, Tzyy-Wen, Harn, Horng-Jyh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7137364/ https://www.ncbi.nlm.nih.gov/pubmed/32269942 http://dx.doi.org/10.4103/tcmj.tcmj_182_19 |
Ejemplares similares
-
The Role of Biomaterials in Implantation for Central Nervous System Injury
por: Chen, Yu-Shuan, et al.
Publicado: (2018) -
Good Manufacturing Practice (GMP) Compliance for Phage Therapy Medicinal Products
por: Bretaudeau, Laurent, et al.
Publicado: (2020) -
Chinese herbs and acupuncture to improve cognitive function in Alzheimer's disease
por: WuLi, Wei, et al.
Publicado: (2021) -
Human-Induced Pluripotent Stem Cells and Herbal Small-Molecule Drugs for Treatment of Alzheimer’s Disease
por: Wuli, Wei, et al.
Publicado: (2020) -
N-Butylidenephthalide Inhibits the Phenotypic Switch of VSMCs through Activation of AMPK and Prevents Stenosis in an Arteriovenous Fistula Rat Model
por: Yang, Hsin-Han, et al.
Publicado: (2020)